Log In
Print
BCIQ
Print
Print this Print this
 

THVD-202

  Manage Alerts
Collapse Summary General Information
Company TheraVida Inc.
DescriptionOnce-daily formulation of tolterodine and pilocarpine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB) and urge urinary incontinence
Regulatory Designation

Partner

SK Chemicals Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today